Article
Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment | TechCrunch
Rating:
2.0
Views:
19
Likes:
1
Library:
1
A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Neurovalens, a Belfast-based startup that's been developing technology to deliver noninvasive electrical stimulation of the brain and nervous system for almost a decade, has had its second head-mounted treatment device cleared by the FDA.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value